JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Scaphocapitolunate arthrodesis.

Since 1985 scaphocapitolunate arthrodesis has been performed on 21 patients with either chronic incompetence of the scapholunate ligament or a scaphoid nonunion. The average age was 31 years; follow-up averaged 28 months. Eighty-six percent of the injuries involved workers' compensation. The operative procedure was done through a dorsal approach, with the use of autogenous bone grafting and Kirschner wire fixation. Eight-one percent healed after the primary procedure; one patient had a major infection. Range of motion averaged 35 degrees of extension, 30 degrees of flexion, 10 degrees of radial deviation, and 20 degrees of ulnar deviation. Grip strength averaged 70% of the uninvolved side. Pain was significantly reduced in 80% of the patients. Sixteen of 20 patients were able to return to work. Radiographic examination at final follow-up showed mild degenerative changes at the radiocarpal joint in two patients.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app